TG Therapeutics | TGTX - Stock


TG Therapeutics reported $146.95M in Stock for its fiscal quarter ending in September of 2025.





Stock Change Date
AbbVie USD 4.95B 13M Dec/2025
Amgen USD 6.22B 121M Dec/2025
Ardelyx USD 129.36M 107.08M Sep/2025
Arrowhead Research USD -173.08M 173.08M Dec/2024
Bayer EUR 12.33B 221M Sep/2025
Biogen USD 2.17B 41.3M Dec/2025
Corcept Therapeutics USD 12.87M 519K Dec/2025
Gilead Sciences USD 1.78B 40M Sep/2025
Infinity Pharmaceuticals USD 0 0 Sep/2021
J&J USD 14.19B 45M Dec/2025
Karyopharm Therapeutics USD 3.97M 1.03M Sep/2025
Novartis USD 6.42B 114M Sep/2025
Novavax USD 13.51M 3.27M Sep/2025
PTC Therapeutics USD 79.65M 26.96M Dec/2025
Puma Biotechnology USD 9.48M 885K Sep/2025
Regeneron Pharmaceuticals USD 3.2B 53.6M Dec/2025
Roche Holding CHF 7.6B 9M Jun/2025
TG Therapeutics USD 146.95M 8.25M Sep/2025
Vertex Pharmaceuticals USD 1.69B 60M Dec/2025